|
|
||||||||
Case Report |
1 Department of Radiology, Kurume University School of Medicine, 67 Asahi-machi,
Kurume, Fukuoka 830-0011, Japan.
2 Department of Radiology, Yokokura Hospital, Omuta, Japan.
Received April 12, 2005;
accepted after revision June 24, 2005.
Address correspondence to K. Fujimoto
(kimichan{at}med.kurume-u.ac.jp).
Keywords: arteriovenous malformation of bronchial artery chest congenital malformations MDCT MRI 3D CT
|
|
|---|
|
|
|---|
|
|
|
A test injection was made of 20 mL of contrast medium (iopamidol [Iopamiron 370 mg I/mL, Nihon Schering]) at a rate of 3.5 mL/s for determining the chest circulation time for the contrast-enhanced imaging (120 kV; 50 mAs; rotation time, 30 seconds). Immediately after the administration of contrast medium, 30 mL of physiologic saline (sterile isotonic 0.9% saline solution) was administered at a rate of 3 mL/s with an autoinjector (Dual-Shot, Nemoto-Kyorindo) via the cubital vein. As a result of the test injection, scanning was started 9 seconds (pulmonary artery phase) and 23 seconds (pulmonary vein and thoracic aorta phase) after initiation of the contrast injection; the former was termed the "venous phase" and the latter was termed the "arterial phase." In these scans, 40 mL of Iopamiron 370 mg I/mL at 3.5 mL/s and 50 mL of 0.9% physiologic saline (at 3 mL/s) were used.
Three-dimensional reconstruction was performed with a section thickness of 1 mm and a reconstruction interval of 0.6 mm. After completion of 3D CT data acquisition, the arterial phase image was colored red and the venous phase image was colored blue manually. The fusion image was made by superimposing the arterial phase image on the venous phase image using a workstation (M900QUADRA, Zio Software).
The 3D-reconstructed arterial phase and venous phase fusion image (Fig. 1D) clearly revealed an enlarged and tortuous bronchial artery (shown in red) arising from the descending aorta, initially ascending and then descending toward an aneurysmal change on the right posterior basal pulmonary artery (Fig. 1E). The right posterior basal pulmonary artery was colored red, and the thoracic aorta and bronchial artery, in contrast to other pulmonary arteries, were colored blue because of differing attenuation values obtained from region-of-interest measurements.
|
|
These CT findings indicated a left-to-right shunt, forming a communication between the bronchial artery and pulmonary artery through a vascular aneurysmal change. There was no evidence of abnormality in the lung parenchyma found on CT. On the basis of these findings, a diagnosis of primary bronchial AVM was made. The patient was asymptomatic and no angiography or treatment was performed. The bronchial AVM had not changed in size or shape on follow-up MDCT angiography 16 months after initial MDCT.
|
|
|---|
Iwasaki et al. [2] reported that hyperplastic changes in the bronchial arteries often develop secondarily after inflammatory lung disease or pulmonary neoplasm. Cain and Spanel [5] proposed that cases without inflammation be called "primary angioma arteriovenosum racemosum" (the same disorder of the present case). To differentiate between primary (congenital) or secondary (due to inflammatory lung disease or pulmonary neoplasm) bronchial AVM, we propose the following diagnostic criteria: normal blood examination results, normal lung findings on chest radiography or CT, and no history of lung disease. Thus, the present case fits the criteria for the primary type.
Although the genesis of bronchial AVM remains uncertain [2, 3, 6], most malformations are believed to be congenital, such as developmental anomaly. It has been reported that bronchopulmonary anastomosis at the precapillary level exists in the normal lung [7], and progressive enlargement occurs with age in response to increasing flow, with eventual necrosis of the vessel wall [6]. This might increase the magnitude of the shunt or cause hemorrhage, leading to clinical detection.
Bronchial AVM can present at any age, occurs predominantly in men [2, 3], and is usually unilateral (especially in the middle and lower lobes) in the right lung more often than in the left lung [3]. The chief complaints are a potentially life-threatening or recurrent hemoptysis and cough [1, 3], but bronchial AVM is rarely found incidentally as an asymptomatic disease [3]. Chest radiography findings reveal no evidence of abnormality, parenchymal infiltrates, or increased vascular markings [3]. No abnormalities were revealed on the chest radiograph in the present case.
MDCT angiography findings for analyzing hemodynamics and bronchial AVM morphology have not been previously reported. In the present case, 3D fusion images obtained by superimposition of the arterial phase on the venous phase indicated an abnormal course and form of the bronchial artery and a left-to-right shunt forming a communication between the bronchial artery and the pulmonary artery. Histopathologic specimens were not obtained, but these CT findings were consistent with bronchial AVM.
Cases have been reported with conventional CT or bronchial arteriography and treatment [1-3]. With the recent development of novel techniques, MDCT angiography is a useful method for evaluating the hemodynamics and morphology of abnormal vessels without routine angiography. In the presented methods, a dual injector (one holding a syringe with contrast medium and the other holding a syringe with physiologic saline) was required to differentiate the effects of contrast medium concentrations on the pulmonary arteries from those on the pulmonary vein, aorta, and bronchial artery.
Haage et al. [8] reported that the injection of 60 mL of 370 mg I/mL of contrast medium followed by a 30-mL saline bolus allows equal or better quality imaging and a reduction of opacification in the superior vena cava when compared with 75 mL of the same contrast material without saline. Although the total amount of contrast medium generally used for thoracic helical CT varies between 75 and 150 mL [8], the present method required only 60 mL (20 mL in the test injection and 40 mL in MDCT angiography). Furthermore, diluting chest blood with physiologic saline can reduce perivenous artifacts, particularly in the superior vena cava.
For the treatment of a life-threatening or recurrent hemoptysis, surgical resection of the aneurysmal change in the lung parenchyma, ligation of the bronchial artery, and bronchial artery embolization have been reported [1-3, 6]. However, the natural course of this condition remains uncertain, and the necessary radical treatment has not been established [1-3, 6]. In the present case, because the patient was asymptomatic and the left-to-right shunt and small aneurysmal change were not considered to be life-threatening, we did not perform further examinations or therapy.
In conclusion, MDCT angiography is a noninvasive technique for evaluating hemodynamics and abnormal conditions of the bronchial artery without bronchial arteriography. In addition, MDCT angiography using the presented methods can reduce the total amount of contrast material and avoid perivenous artifacts caused by the contrast medium.
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |